Načítá se...
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic pathways such as enhanced glycolysis, lipogenesis and/or autophagy and treatment resistance may occur in cancer...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938987/ https://ncbi.nlm.nih.gov/pubmed/23994756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mam.2013.08.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|